MPS VI Clinical Surveillance Program (CSP)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00214773

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:14.219608+00:00

Published At

2021-04-05T00:00:00+00:00

Record Updated At

2021-04-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-04-05"

protocolSection.identificationModule.nctId

"NCT00214773"

protocolSection.identificationModule.officialTitle

"MPS VI Clinical Surveillance Program (CSP)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.